{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:37:08Z","timestamp":1780353428666,"version":"3.54.1"},"reference-count":74,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:p>\n                    Non\u2010muscle\u2010invasive bladder cancer (NMIBC) is the most common form of bladder cancer, with frequent recurrences and risk of progression. Risk\u2010stratified treatment and surveillance protocols are often used to guide management. In 2017,\n                    <jats:italic>BJUI<\/jats:italic>\n                    reviewed guidelines on NMIBC from four major organizations: the American Urological Association\/Society of Urological Oncology, the European Association of Urology, the National Comprehensive Cancer Network, and the National Institute for Health and Care Excellence. The present update will review major changes in the guidelines and broadly summarize new recommendations for treatment of NMIBC in an era of bacillus Calmette\u2010Gu\u00e9rin shortage and immense novel therapy development.\n                  <\/jats:p>","DOI":"10.1111\/bju.14915","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T16:04:54Z","timestamp":1570637094000},"page":"197-205","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Update on the guideline of guidelines: non\u2010muscle\u2010invasive bladder cancer"],"prefix":"10.1111","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2190-7309","authenticated-orcid":false,"given":"Jacob","family":"Taylor","sequence":"first","affiliation":[{"name":"Department of Urology NYU Langone Health New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezequiel","family":"Becher","sequence":"additional","affiliation":[{"name":"Department of Urology NYU Langone Health New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary D.","family":"Steinberg","sequence":"additional","affiliation":[{"name":"Department of Urology NYU Langone Health New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,11]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"Cancer incidence mortality and prevalence by cancer site Internet. IARC 2018. Available at:http:\/\/gco.iarc.fr\/today\/data\/factsheets\/populations\/900-world-fact-sheets.pdf. Accessed October2019"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.06.010"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1142"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.41.0183"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.06.042"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605637"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.1307055"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13760"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.06.049"},{"key":"e_1_2_6_11_1","unstructured":"FlanniganR EdneyM Maddox-SmithA HarrisR EvansC NaglerH.BCG shortage notice: American Urological Association 2019. Available at:https:\/\/www.auanet.org\/practice-resources\/bcg-info\/bcg-shortage-notice. Accessed July 2019"},{"key":"e_1_2_6_12_1","unstructured":"BabjukM BurgerM Comp\u00e9ratEet al.EAU guidelines on non\u2010muscle\u2010invasive urothelial carcinoma of the bladder: update 2019. Edn. Presented at the EAU Annual Congress Barcelona 2019: EAU Guidelines Office 2019"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"e_1_2_6_14_1","unstructured":"FlaigTW SpiessPE AgarwalNet al.NCCN Clinical Practice Guidelines in Oncology Bladder Cancer Version 3 2019 2019. Available at:https:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/bladder.pdf. Accessed July 2019"},{"key":"e_1_2_6_15_1","unstructured":"BagnallP CattoJ ChandraAet al.Bladder cancer: diagnosis and management. National Institute for Health and Care Excellence 2015"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-018-2438-9"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2019.04.016"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13354"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1089\/end.2010.0319"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13265"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-199907000-00018"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.02.014"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.10.061"},{"key":"e_1_2_6_24_1","volume-title":"Cancer Staging Manual","author":"Springer","year":"2010"},{"key":"e_1_2_6_25_1","volume-title":"International Union Against Cancer","author":"Wiley\u2010Blackwell","year":"2009"},{"key":"e_1_2_6_26_1","volume-title":"Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs","author":"Eble JN","year":"2004"},{"key":"e_1_2_6_27_1","volume-title":"Histological typing of urinary bladder tumors","author":"Mostofi FK","year":"1973"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.02.028"},{"key":"e_1_2_6_29_1","unstructured":"BabjukM BurgerM ComperatEet al.EUA Guidelines on Non\u2010muscle\u2010invasive Bladder Cancer (TaT1 and CIS). European Association of Urology 2018"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.11.096"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-019-0184-4"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.06.009"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2013.0060"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.05.050"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.12.056"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2013.04.006"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1615697"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.06.025"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.4657"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.04.038"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2003.11.049"},{"key":"e_1_2_6_42_1","first-page":"CD006885","article-title":"Intravesical bacillus Calmette\u2010Guerin versus epirubicin for Ta and T1 bladder cancer","volume":"5","author":"Shang PF","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.12.024"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67707-5"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.10.039"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.06.045"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13474"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.06.028"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-159002"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.4070"},{"key":"e_1_2_6_51_1","unstructured":"US Food & Drug administration \u2013 Inspections Compliance Enforcement and Criminal Investigations \u2013 Sanofi Pasteur 7\/12\/12 Warning Letter 2012."},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-179018"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-9056(18)30035-6"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000173919.28835.aa"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.2002.02722.x"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.04.062"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2018.08.015"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-006-0112-0"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67799-3"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2012.04.010"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-150008"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2017.01.018"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13088"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2013.01.009"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.04.012"},{"key":"e_1_2_6_66_1","volume-title":"Evolving Landscape of BCG\u2010Unresponsive Disease: Where Are We in 2019?","author":"Agarwal P","year":"2019"},{"key":"e_1_2_6_67_1","doi-asserted-by":"crossref","unstructured":"deWitR KulkarniGS UchioEet al. eds.Pembrolizumab for High\u2010Risk (HR) Non\u2013Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette\u2010Gu\u00e9rin (BCG): Phase 2 KEYNOTE\u2010057 Trial. ESMO 2018 Congress; 2018: Annals of Oncology","DOI":"10.1093\/annonc\/mdy283.073"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2017.07.005"},{"key":"e_1_2_6_69_1","doi-asserted-by":"crossref","unstructured":"PackiamVT editor CG0070. An Oncolytic Adenovirus for BCG\u2010Unresponsive Non\u2010Muscle\u2010Invasive Bladder Cancer (NMIBC): 18 Month Follow\u2010Up from a Multicenter Phase II Trial. American Urological Association 2019 Annual Meeting 2019; Chicago IL","DOI":"10.1097\/01.JU.0000556225.57786.36"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.3064"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2018.03.099"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14643"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.06.030"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09980.x"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017913"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbju.14915","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.14915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:52:04Z","timestamp":1761731524000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.14915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1111\/bju.14915"],"URL":"https:\/\/doi.org\/10.1111\/bju.14915","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"2019-11-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}